Another comprehensive portfolio of API and intermediates are under development. To have the latest status please contact with us.
Anagliptin
Lesinurad
Naloxegol Oxalate
Fexofenadine HCl
Tofacitinib Citrate
Montelukast Sodium
Methyl 3- oxovalerate
3-Aminopyrazine -2- carboxylic acid